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Summary The promotion of 7,12-dimethylbenzanthracene (DMBA) induced mammary cancer in Wistar rats
by a 4% cholestyramine (CHST) diet was investigated. The rats, 50 days of age, were divided into six groups.
First two groups were given an intragastric dose of 0.8ml ofcorn oil whereas the remaining four groups were
given a single intragastric dose of 5 mg of DMBA dissolved in 0.8ml of corn oil. After 1 week on laboratory
chow the first two groups and two groups treated with DMBA were fed a control diet and the two remaining
groups treated with DMBA were fed a 4% CHST diet. Half the animals were killed at 100 days and the
remainder at 200 days. A detailed histologic examination of grossly normal mammary tissue as well as any
tumour mass was made for each rat. The serum lipids were extracted and the individual neutral lipid
composition was determined. In rats treated with DMBA and fed a 4% CHST diet, the incidence of
malignant tumours increased by 5 fold, and the tumour weight by 12 fold. In addition, the serum total lipids,
cholesterol esters and triglycerides decreased significantly when compared with rats fed a control diet. These
results suggest that CHST diet promotes DMBA induced mammary cancers in Wistar rats.
Cholestyramine (CHST), an insoluble quarternary am- Materials and methods
monium anion exchange resin is not absorbed from the
gastrointestinal tract. Administered orally, CHST promotes Animals and diets
faecal elimination of bile acids, stimulates de novo cholestero-
genesis in liver and reduces both total and low density A total of 36 female rats of Wistar Strain, 35 days old
lipoprotein (LDL) plasma cholesterol levels in humans (Hilltop Laboratory Animals Inc. Scottdale, PA) were
(Myant, 1981). Indeed, clinical studies have shown that housed 2 per cage in a room with controlled temperature
treatment with CHST coupled with diets high in unsaturated and humidity, 12h light (7a.m. to 7p.m.) and dark (7p.m.
fatty acids reduce total serum cholesterol levels by 8%, LDL to 7a.m-) cycle and were given food and water ad libitium.
cholesterol levels by 12%, resulting in a 19% reduction in At 50 days of age, they were divided into 6 groups and
deaths due to coronary heart disease (CHD). Based on these subjected to the following treatments: 4 animals each in
studies it has been widely accepted that a reduction in the groups a and b were given a single intragastric dose of 0.8ml
serum cholesterol levels will significantly reduce the risk of corn oil alone by a stomach tube; 5 animals in group c, 7
CHD in humans (Rifkind, 1986). While this conclusion may animals in group d, 6 animals in group e, and 10 animals in
be warranted, some epidemiological studies have shown that group f were each given 5mg of DMBA dissolved in 0.8 ml
a reduction in serum cholesterol levels resulted in increased of corn oil. All the animals were fed laboratory chow (Allied
incidence of all cancers and colon cancer in particular Mills Inc., Chicago, IL) for the next 7 days, then switched to
(Graham 1984). Some scientists concluded that treatment semipurified diets (ICN Pharmaceuticals Inc. Cleveland,
with cholestyramine increases the risk for cancer (Vitale & OH). The control semipurified diet (AIN) was prepared as
Ross, 1985). If indeed CHST or low serum cholesterol levels recommended by the American Institute of Nutrition (Bieri
increase the risk for cancer, the mechanism by which this is et al., 1977). This diet contained 50g sucrose, 20g casein,
brought about is unknown. There are only three published 15g corn starch, 0.3g methionine, 5g cellulose, 5g corn oil,
reportsa which showed conclusively that CHST promotes 1 g vitamin mixture, 3.5 g mineral mixture and 0.2g choline.
cancers in rats. Nigro et al (1973) showed that at 2% level A 4% CHST diet was prepared by substituting 4g of pure
in the dietn CHST promotes colon cancer in male Sprague- cholestyramine resin (Bristol-Meyers Company, Evensville,
Dawley rats initiated with either azoxymethane methylazoxy IN) to 4g of corn starch in the control diet (AIN). Groups
methanol or dimethylhydrazine (DMH). Later studies a-d were fed AIN diet, whereas groups e and f were fed a
confirmed the above ftindings and showed that CHST 4% CHST diet throughout the period of experiment. All the
promotes DMH induced colon cancers in germ free rats animals had free access to food and water. Groups a, c and e
(Asano et al., 1975). Recently it was reported that CHST at were sacrificed at the end of 100 days and groups b, d and f
2, 6 and 10% level in the diet stimulates pancreatic growth, were sacrificed at the end of .200 days. The animals were
protein and DNA synthesis in Wistar rats. It was also killed at 9a.m. by bleeding through the abdominal aorta and
suggested that CHST promotes pancreatic carcinogenesis serum was separated from blood by low speed centrifugation
(Brand & Morgan, 1982). Bile acids were implicated as the and frozen at -20°C until analysed. The livers, six pairs of
agents promoting cancers of colon and pancreas and the low mammary glands and tumours if any were resected, weighed
serum cholesterol levels or some other metabolic changes and processed for further analyses.
induced by a CHST diet were never considered as the
possible mitogenic signal(s). Moreover, it is not known, Histology
whether orally administered CHST can promote cancers Slices of breast tissues and tumours were fixed in Stieve's
other than those of digestive tract. solution and embedded in paraffin. Sections (4tim), were
For these reasons we have induced breast cancer in female stained with hematoxylin and eosin (H&E) for histologic
Wistar rats by a single intragastric dose of 7,12-dimethyl- examination (Rao et al., 1984b). A detailed histologic
benzanthracene and fed a control or a 4% CHST diet. The evaluation of grossly normal mammary tissue as well as any
histopathological changes in breast tissue, the presence Of tumour mass was made for each rat according to the
malignant tumours and the serum lipid composition were procedure of Young and Hallowes (1973).
analysed after 100 and 200 days of diet feeding.
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analysed by the methods previously described (Rao et al. possible to correlate preneoplastic lesions present at 100 days
1980; 1983; 1984a, 1986b). Neutral lipids were separated into with the development of malignant tumours at 200 days by
cholesterol esters (CHE), free fatty acids (FFA), triglycerides histologic procedures adopted in these studies. These
(TG) and free cholesterol (CH) by thin-layer correlations, if any, can be made in future studies by whole
chromatography on silica gel G plates using the solvent mount analysis of mammary glands and counting hyper-
system n-heptane:isopropyl ether:glacial acetic acid plastic nodules (Beuving et al., 1967). Papillomas (Figure IE)
(60:40:2, v/v). The plates were air dried and the individual and fibroadenomas (Figure IC) were present only in rats fed
bands were identified by exposure to iodine vapour. The CHST diet (groups e and f). It was reported that histo-
lipid bands were scraped from the thin-layer chromato- logically malignant tumours, showing clear stromal or
graphic plates and eluted with 10ml of chloroform and muscle invasion and malignant nuclear features, occur in
estimated (Rao et al., 1980, 1984b). lower incidence than palpable tumours (Rogers et al., 1986).
Indeed, we have observed that counting palpable tumours
Other procedures gives misleading conclusions. There were no palpable
Statistical analysis of the data was performed using analysis tumours in any group at 100 days. At 200 days, in rats
treated with DMBA and fed AIN diet (group d) out of 2 of variance (Steel & Torrie, 1980), and differences between pale tuMor int rat oN one was foun o b
menswee onidre sinfcn if P<0.05. palpable tumours in two rats only one was found to be
adenocarcinoma (Figure lA). On the other hand, 5 rats
treated with DMBA and fed CHST diet (group f) showed 17
palpable tumours. However, histologic examination revealed
Results that out of these only 10 were found to be adenocarcinomas
(Figure lA). Two comedocarcinomas (Figure 1B) present in
The effects of DMBA and a 4% CHST diet on the body two more rats were shown in the same column in Table II.
weight, liver weight and weight of total breast tissue were The gross appearance of the tumours varied between small,
evaluated and the results are presented in Table I. The well encapsulated and circumscribed firm tissue to large
average body weight at the start of the experiment was 200g haemorrhagic tumours with focal areas of necrosis and
and the rats consumed - 25 g of either a control diet or 4% occasional ulceration through the skin. The average tumour
CHST diet per day. Both DMBA and CHST were well weight in group d was 0.55g whereas in group f it was
tolerated by the rats. CHST diet caused a slight but 6.21 g. There were no malignant tumours in rats treated with
significant decrease in body weight at the end of 200 days. corn oil alone and fed AIN diet (groups a and b).
Both DMBA and CHST increased weight of total breast The serum lipid composition of rats treated with and
tissue at the end of 100 but not 200 days, when compared to without DMBA and fed either a control diet (AIN) or
control rats (groups a and b). CHST diet was analysed and the results are presented in
A detailed histological evaluation of grossly normal Table III. TL and TG decreased significantly in rats treated
mammary tissue as well as of any tumour mass was made with DMBA and fed AIN diet (groups c and d) or a CHST
for all the rats and the results are shown in Figure 1 and diet (groups e and f) when compared with control groups
Table II. Lobular hyperplasia (Figure ID) and ductal (groups a and b) at 100 and 200 days. In the same rats, CH
hyperplasia (Figure IF) were present at both 100 and 200 decreased at 100 but not at 200 days. CHE decreased only in
days in all the groups. We have observed that it is not group c at 100 days and only in group f at 200 days when
Table I Effect of DMBA and CHST on final body weight, liver weight and weight of total breast
tissue
Body wt. Liver wt. Breast wt.
Diet DMBA Daysfed Group No. rats (g) (g) (g)
100 a 4 339 + 10* 13.63+0.98 2.28+0.32
AIN - 200 b 4 365+ 17a+ 12.83+1.11 10.78+2.46
100 c 5 328+ 12 13.10+0.89 3.86+0.67a
AIN + 200 d 7 378+ 14c 13.33+0.45 11.15+1.04
100 e 6 315+8a 12.58+0.68 4.96+0.68a,c
CHST + 200 f 10 352+ 15 dc 4.98+1.68de 10.82+1.05
AIN, control diet; CHST, 4% cholestyramine diet; DMBA, 7,12-dimethylbenzanthracene.
*Each value is mean +s.e.+P<0.05 considered significant when compared with the group indicated.
Table II Histological classification of mammary tissue and tumours
Average tumour
Diet DMBA Days fed Group No. rats weight (g) Adenocarcinoma Fibroadenoma Papilloma
100 a 4-
AIN - 200 b 4 - - --
100 c 5 - - - -
AIN + 200 d *7 0.55 1(1) - -
100 e 6 - - - 1(1)
CHST + 200 f 10 6.21 12(7) 5(4) 2(2)
AIN, control diet; CHST, 4% cholestyramine diet; DMBA, 7,12-dimethylbenzanthracene. Numbers of animals with
histological lesions are indicated in parentheses.CHOLESTYRAMINE AND BREAST CANCER 47
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Figure 1 Breast tissue sections showing malignant and benign changes. (A) Adenocarcinoma of the breast showing varying
irregular sized, crowded glands lined by hyperchromatic cells with numerous mitotic figures (arrows). (B) Intraductal carcinoma
(comedo carcinoma) showing several layers of neoplastic cells and central necrosis. (C) Fibroadenoma with proliferation of ductal
and stromal components. (D) Lobular hyperplasia showing benign glandular proliferation lined by a single layer of cells. Note the
proteinaceous material secreted in the lumen. (E) Intruductal papilloma showing projection of finger like processes into the lumen
of an enlarged duct. (F) Ductal hyperplasia with proliferation of benign ducts lined by two layers of cells: The outer myoepithelial
cell (arrow) and the inner ductal epithelial cells. Note the loose stromal components. (H&E, x 140).
Table III Effect of DMBA and CHST on serum lipid composition
Diet DMBA Daysfed Group TL CH CHE TG FFA
100 a 684+ 152* 31.4+3.8 97.9+ 14.2 203.5 + 72.2 23.5 + 1.0
AIN - 200 b 685+ 39 29.2+ 1.9 97.4+ 3.3 297.6+ 16.9a 25.7 +2.0
100 c 524+44a 19.0+2.4a 70.9+8.7a 173.1 +22.9 24.7+2.8
AIN + 200 d 604+49bc 26.2+2.2c 107.4+3.8bc 157.4+31.4b 34.6+6.0b c
100 e 540+31a 23.2 + 3.1a.c 91.3 +2.6c 128.8 + 18.8ac 25.9 +0.45
CHST + 200 f 517+28bd 34.1 +2. b d C 86.3 +2.6b de 165.4+27.3b c 37.3+5.4c
AIN, control diet; CHST, 4% cholestyramine diet; DMBA, 7,12-dimethylbenzanthracene; TL, total lipids; CH, cholesterol;
CHE, cholesterol ester; TG, triglycerides; FFA, free fatty acids.
*Mean+s.e. of four rats+ P<0.05 considered significant when considered with the group indicated. Values are in
mg/100 ml - 1 of sera.
compared with control rats (groups a and b). FFA increased feeding. The results clearly establish that a CHST diet
significantly in groups d and f at 200 days when compared promotes DMBA induced mammary cancers in Wistar rats.
with control rats (group b). The mechanism of this tumour promotion is not known at
the present time.
Studies by other investigators showed that dietary CHST
Discussion promotes cancers of colon (Nigro et al., 1973; Asano et al.,
1975) and pancreas (Brand & Morgan, 1982). In these
The end point of this study is the size and the incidence of studies bile acids were implicated as the cause of the tumour
malignant tumours (Figure 1; Table II) after 200 days of diet promotion. While such a mechanism is certainly conceivable48 M.F. MELHEM et al.
for the enhancement of carcinogenesis in colon and pancreas,
we suggest that mammary cancer promotion by a CHST diet
may occur through some other mechanism. Since CHST diet
was fed 1 week after DMBA treatment of the animals, it is
reasonable to assume that CHST mediated its effect at the
promotion but not at the initiation stage of tumorigenesis.
CHST is an insoluble resin and orally administered CHST is
not absorbed through the gastrointestinal tract; therefore,
CHST cannot reach the target tissue to cause any local
effect. Instead of commercially available Questran (R)
(Mead-Johnson, Evansville, IN) we have used a pure CHST
resin in the preparation of the diet; the potential of additives
and contaminants present in commercial preparations to
cause enhanced tumour incidence can therefore be ruled out.
It is therefore, reasonable to conclude that the metabolic
alteration induced by a CHST diet, rather than CHST resin
per se causes tumour promotion.
Contrary to previous reports involving short term feeding
protocols (Huff et al., 1963; Gallo et al., 1966), feeding a
CHST diet for 200 days does decrease serum total lipids,
cholesterol esters and triglycerides (Table III). Since LDL
accounts for 10 to 20% and major lipoproteins in the rat are
high density lipoproteins (HDL) (Coleman & Levietes, 1981)
a reduction in TL, CHE and TG by a CHST diet in the
present study represents a significant reduction in circulating
LDL levels. A recent study clearly showed a significant
increase in methylnitrosourea induced mammary cancers and
a significant decrease in serum cholesterol and triglyceride
levels in rats fed unsaturated fatty acid (USF) diet when
compared to the same rats fed diets rich in saturated fats
(Cohen et al., 1986). Similar to CHST (Myant, 1981) USF
diets also eliminate bile acids, stimulate de novo cholestero-
genesis and decrease serum cholesterol esters (Ramesha et
al., 1980). Thus, there is enough direct and indirect evidence
to conclude that a reduction in serum LDL provides the
mitogenic signal.
Three lines of evidence give credence to such a possibility.
First, rat extrahepatic tissues have functioning high affinity
LDL receptors and the rates of endogenous cholesterol
synthesis in a number of rat tissues can be increased by
drastically lowering plasma lipoprotein levels. Intravenous
infusion of LDL was shown to reduce the rates of
cholesterol synthesis in some of the tissues examined towards
control values (Anderson & Dietschy, 1977). Second, there is
evidence to suggest that extrahepatic tissues take up mostly
LDL cholesterol (Brown et al., 1981). Finally, there is a
synchrony between de novo cholesterogenesis and DNA
synthesis (Rao et al., 1984a; Siperstein, 1984). We showed
that during cell proliferation there is a reduction in
circulating cholesterol esters resulting in their reduced influx
(Rao et al., 1986) and a stimulation of de novo cholestero-
genesis and hexose monophosphate pathway (Rao et al.,
1983; 1984a, b; Pani et al., 1984).
That a decrease in serum LDL levels by a CHST diet leads
to reduced influx of circulating cholesterol esters which
removes inhibition on 3-hydroxy-3-methyl glutaryl coenzyme
A reductase leading to enhanced de novo cholesterogenesis,
DNA synthesis and cell proliferation in breast tissue needs
to be established by further experimentation.
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